Skip to main content
. 2024 Jul 10;51(2):e238267. doi: 10.14503/THIJ-23-8267

Fig. 2.

Kaplan-Meier estimates show survival without POCEs at 2-year follow-up for (A) HAS-BLED, (B) HEMORR2HAGES, and (C) PARIS risk scores.

Fig. 2

HAS-BLED, Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile International Normalized Ratio, Elderly, Drugs/Alcohol; HEMORR2HAGES, Hepatic or Renal Disease, Ethanol Abuse, Malignancy, Older Age, Reduced Platelet Count or Function, Re-Bleeding, Hypertension, Anemia, Genetic Factors, Excessive Fall Risk and Stroke; PARIS, Patterns of non-Adherence to Anti-Platelet Regimen in Stented Patients; POCE, patient-oriented composite end point.